RxDoctor Payments Data

Phong le, MD

Otolaryngology · Wichita, KSNPI 1841604956

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Stryker at 53.9% of the total. Reporting peaked in 2019 at $2,390 and has fallen 74.5% since, to $608 in 2025.

$4,155in general payments, 2019–2025

Across 77 payments — averaging $53.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Intersect ENT, Inc.$319
  • GSK$251
  • Cochlear Americas$232
  • Medtronic$223
  • Aerin Medical Inc.$199
  • plus $695 from 14 others

What the payments were for

  • Travel & lodging$1,94047%
  • Food & beverage$2,18152%
  • Education$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,155 in reported general payments places this provider in the 75th percentile of 87 otolaryngology providers in Kansas.

See all otolaryngology providers in Kansas

Medicare billing

Part B allowed, 2024
$260,187
Medicare patients
866
Services billed
5,588

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Epinephrine11$1,884
Fluticasone Propionate163$1,852
Ipratropium Bromide35$1,715
Ofloxacin53$1,524
Azelastine Hcl83$1,241
Fluocinolone Acetonide Oil24$1,109
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav89$933
Omeprazole105$890
Dexamethasone Sodium Phosphate19$774
Clobetasol Propionate13$572
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen76$568
Ondansetron OdtOndansetron75$565
Levocetirizine Dihydrochloride48$562
Cefdinir21$392
Doxycycline Hyclate27$341

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →